Prevention of maternal sensitization to the Rh factor.
D000917:Antibody Formation; D001782:Blood Donors; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis / Q000592:standards / Q000627:therapeutic use*; D008297:Male; D008404:Massachusetts; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System